lung cancer

3 Shocking Biotech Flops of 2016 So Far
Motley Fool
Fri, 07/8/16 - 11:01 am
biotech
Rintega
Celldex Therapeutics
glioblastoma
Clovis Oncology
rociletinib
lung cancer
NewLink Genetics
algenpantucel-L
pancreatic cancer
What AbbVie Bought for $5.8 Billion
Motley Fool
Mon, 06/6/16 - 11:25 am
AbbVie
Stemcentrx
M&A
Rova-T
lung cancer
Merck, Bristol drugs show longer survival for deadly cancers
Yahoo/Reuters
Thu, 05/19/16 - 09:59 am
Merck
Bristol-Myers Squibb
cancer immunotherapy
lung cancer
melanoma
Opdivo
Keytruda
ASCO 2016
Eli Lilly Just Lost the Latest Round in its Patent Battle
Fortune
Fri, 02/12/16 - 10:01 am
Eli Lilly
patents
Alimta
lung cancer
UK
Allergan
generics
AstraZeneca's potential lung cancer blockbuster nabs EU approval
BioPharma Dive
Thu, 02/4/16 - 06:25 pm
AstraZeneca
lung cancer
Europe
Tagrisso
Incyte and AstraZeneca Announce New Lung Cancer Clinical Trial Collaboration
Yahoo
Mon, 01/11/16 - 08:34 am
Incyte
AstraZeneca
lung cancer
clinical trials
INCB39110
JAK inhibitors
This Is the Most Effective Way to Treat Lung Cancer, Study Shows
Motley Fool
Mon, 12/28/15 - 09:49 am
lung cancer
Galena Biopharma
Inovio
Merck
Bristol-Myers Squibb
Merck CEO: Using Keytruda Could Extend Patient's Life By 13 Months On Average
Yahoo/Benzinga
Tue, 12/22/15 - 10:37 am
Merck
Kenneth Frazier
Keytruda
lung cancer
AstraZeneca hit with setback as durvalumab falls further behind on lung cancer
Fierce Biotech
Sat, 12/19/15 - 11:28 am
AstraZeneca
durvalumab
PDL-1 inhibitors
lung cancer
[video]Top FDA Drug Approvals in 2015: Lung Cancer
Motley Fool
Tue, 12/8/15 - 10:41 pm
FDA
lung cancer
AstraZeneca
Tagrisso
AstraZeneca wins big with fast FDA OK of AZD9291 for lung cancer
Fierce Biotech
Fri, 11/13/15 - 08:38 pm
AstraZeneca
FDA
fast track
AZD9291
lung cancer
Merck's Keytruda extends survival in lung cancer study
Yahoo/Reuters
Mon, 10/26/15 - 04:32 pm
Merck
Keytruda
lung cancer
anti-PD-1 immunotherapy
Going After Customized Lung Cancer Vaccines, Gritstone Grabs $102M
Forbes
Tue, 10/20/15 - 06:05 pm
vaccines
Gritstone Oncology
lung cancer
cancer immunotherapy
AstraZeneca halts a pair of lung cancer trials over a safety scare
Fierce Biotech
Fri, 10/9/15 - 10:03 am
AstraZeneca
lung cancer
clinical trials
durvalumab
AZD9291
Racing AstraZeneca, Clovis gets a speedy FDA review for its lung cancer drug
Fierce Biotech
Wed, 09/30/15 - 04:43 pm
AstraZeneca
Clovis Oncology
FDA
rociletinib
lung cancer
Roche says new drug shows benefits in lung, bladder cancer tests
Yahoo/Reuters
Sun, 09/27/15 - 08:47 pm
Roche
lung cancer
bladder cancer
atezolizumab
New data expected at lung-cancer conference on experimental drug combos
Medical Marketing and Media
Fri, 09/4/15 - 09:01 am
lung cancer
Opdivo
Yervoy
Bristol-Myers Squibb
tremelimumab
MEDI4736
AstraZeneca
Roche
atezolizumab
FDA clears GE Healthcare’s low-dose lung cancer CT
Mass Device
Mon, 08/17/15 - 11:08 am
GE Healthcare
devices
FDA
lung cancer
CT Scan
Boehringer bets up to $730M on a new lung cancer drug
Fierce Biotech
Wed, 07/29/15 - 09:49 pm
Boehringer Ingelheim
Hanmi Pharmaceutical
lung cancer
HM61713
Lilly's Alimta gets rating boost in update to ASCO's drug scorecard
Fierce Pharma
Wed, 07/15/15 - 12:23 pm
Eli Lilly
Alimta
ASCO
lung cancer

Pages